The score is held up primarily by financial resilience (very low leverage) and strong recent revenue growth, but is weighed down by the return to losses, negative free cash flow, and a clearly weak technical trend with the price below all major moving averages. Valuation is also less supportive due to the negative P/E and no dividend data.
Positive Factors
Low leverage / strong balance sheet
Morpho's balance sheet shows effectively no debt and substantial equity, giving the company low financial risk and flexibility. This durable low-leverage position supports investment, M&A optionality, and resilience through downturns without near-term refinancing pressure.
Sharp revenue rebound with healthy gross margin
A large revenue rebound in 2025 paired with ~55% gross margins signals demand recovery and structurally strong unit economics. If sustained, this combination enables operating leverage as scale returns and supports longer-term margin sustainability even if operating costs are managed.
Operating in Software - Application
Being in the Software - Application sector positions Morpho in a structurally favorable industry with scalable products and historically higher gross margins. This sector exposure supports durable revenue potential and margin expansion opportunities as products scale and adoption deepens.
Negative Factors
Return to net losses
The swing from ~9% net margin in 2024 to a small loss in 2025 shows earnings volatility and execution risk. Persistent variability in profitability undermines predictable cash flow, complicates strategic planning, and raises the bar for consistent long-term shareholder returns.
Negative free cash flow / weak cash conversion
Free cash flow turning negative in 2025, after a prior positive year and periods of cash burn, signals inconsistent cash conversion. This constrains reinvestment, increases reliance on external funding if growth continues, and heightens financial vulnerability during weaker demand periods.
Inconsistent earnings and cash generation
The firm's mixed financial profile — strong revenue spikes but volatile profits and cash — indicates underlying execution and business-model consistency issues. Over the medium term this inconsistency makes forecasting, capital allocation, and sustaining margins more difficult for management.
Morpho, Inc. (3653) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥3.61B
Dividend YieldN/A
Average Volume (3M)24.81K
Price to Earnings (P/E)―
Beta (1Y)1.08
Revenue Growth1.78%
EPS Growth-125.35%
CountryJP
Employees162
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)-71.31
Shares Outstanding5,508,500
10 Day Avg. Volume14,970
30 Day Avg. Volume24,810
Financial Highlights & Ratios
PEG Ratio0.51
Price to Book (P/B)1.36
Price to Sales (P/S)1.46
P/FCF Ratio-132.87
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Morpho, Inc. Business Overview & Revenue Model
Company DescriptionMorpho, Inc. engages in the research, development, and licensing of artificial intelligence (AI) and image processing technologies in Japan, the United States, China, South Korea, Europe, and internationally. It offers image processing products, such as image stabilization and noise reduction; video stabilization; video generation; video processing software package; noise reduction in video; HDR image generation; DR-corrected image generation; panorama image generation for selfie photography; motion vector detection; photo effect filters library; image super resolution; frame interpolation; cinemagraph; and smooth camera switching for zooming. The company also provides AI products, that includes fast AI inference engine, image enhancement by AI Based segmentation and pixel filtering, pose estimation, bokeh image generation using dual cameras, image classification, object detection, single camera background blur, image segmentation, object tracking, automatic mask generation, automatic wipe generation, and training data for AI development. Its solutions are used in smart devices, automotives, semiconductors, medical products, digital media, and smart city. The company was incorporated in 2004 and is headquartered in Tokyo, Japan.
Morpho, Inc. Financial Statement Overview
Summary
Financial profile is mixed: revenue rebounded sharply in 2025 (+239% YoY) and gross margin stayed healthy (~55%), but profitability weakened (back to a small net loss) and free cash flow turned negative. The balance sheet is a major strength with effectively no debt, but inconsistent earnings and cash generation reduce the score.
Income Statement
58
Neutral
Revenue growth accelerated sharply in 2025 (about +239% year over year), showing a meaningful rebound in demand. Profitability, however, weakened versus 2024: the company moved from a solid profit in 2024 (about 9% net margin) back to a small loss in 2025 (about -2% net margin), and operating profitability also compressed. Gross margin remains healthy (~55% in 2025), but the recent swing back to losses highlights execution risk and earnings volatility.
Balance Sheet
86
Very Positive
The balance sheet is a key strength: debt is effectively minimal (debt-to-equity near zero across periods, and zero in 2025), indicating low financial risk and strong flexibility. Equity remains substantial relative to assets, providing a solid cushion. The main weakness is returns to shareholders: return on equity turned negative again in 2025 after a strong 2024, reflecting inconsistent profitability rather than balance-sheet stress.
Cash Flow
42
Neutral
Cash generation deteriorated materially in 2025: operating cash flow was only slightly positive and free cash flow turned negative, reversing 2024’s positive free cash flow. Earlier years also show sizeable cash burn (negative operating and free cash flow in 2021–2023), pointing to volatility in cash conversion and reinvestment needs. While the low-debt profile reduces liquidity pressure, the recent negative free cash flow is a clear near-term concern.
Breakdown
Oct 2025
Oct 2024
Oct 2023
Oct 2022
Oct 2021
Income Statement
Total Revenue
3.36B
3.30B
2.38B
2.00B
1.73B
Gross Profit
1.84B
1.90B
1.36B
952.07M
866.53M
EBITDA
159.15M
326.88M
-226.63M
-473.41M
-734.07M
Net Income
-77.57M
301.48M
-300.18M
-668.39M
-793.42M
Balance Sheet
Total Assets
4.15B
4.26B
3.71B
3.86B
4.55B
Cash, Cash Equivalents and Short-Term Investments
2.53B
2.94B
2.71B
3.06B
3.39B
Total Debt
10.48M
23.29M
36.25M
12.84M
21.95M
Total Liabilities
526.38M
621.77M
558.59M
460.63M
400.45M
Stockholders Equity
3.62B
3.64B
3.15B
3.40B
4.15B
Cash Flow
Free Cash Flow
-37.01M
65.73M
-365.22M
-477.78M
-694.79M
Operating Cash Flow
14.06M
207.18M
-267.62M
-415.53M
-653.58M
Investing Cash Flow
-413.32M
-140.72M
-92.50M
161.38M
-175.87M
Financing Cash Flow
-9.22M
131.83M
-16.21M
-176.43M
-257.00M
Morpho, Inc. Technical Analysis
Technical Analysis Sentiment
Negative
Last Price847.00
Price Trends
50DMA
800.82
Negative
100DMA
831.43
Negative
200DMA
999.37
Negative
Market Momentum
MACD
-31.36
Positive
RSI
27.97
Positive
STOCH
2.43
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3653, the sentiment is Negative. The current price of 847 is above the 20-day moving average (MA) of 781.65, above the 50-day MA of 800.82, and below the 200-day MA of 999.37, indicating a bearish trend. The MACD of -31.36 indicates Positive momentum. The RSI at 27.97 is Positive, neither overbought nor oversold. The STOCH value of 2.43 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3653.
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 17, 2026